Glycolysis inhibition in tuberculosis-driven metabolic rewiring reduces HIV-1 spread in macrophages
Life Science Alliance · 2026
DOI: 10.26508/lsa.202503333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2026. Verfasst von Zoï Vahlas und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Toulouse, France. Hauptthemen laut MEDLINE: Macrophages, Glycolysis, HIV-1, Tuberculosis. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Tuberculosis (TB) is a significant aggravating factor in individuals living with HIV-1, the causative agent for AIDS. Both Mycobacterium tuberculosis (Mtb), the bacterium responsible for TB, and HIV-1 target macrophages. Understanding how Mtb subverts these cells may facilitate the identification of new druggable targets. Here, we explored how TB can induce macrophages to form tunneling nanotubes (TNT), promoting HIV-1 spread. We found that TB triggers metabolic rewiring of macrophages, increasing their glycolytic ATP production. Using several pharmacological inhibitors, glucose deprivation, and glucose or galactose supplementation, we discovered that disrupting aerobic glycolysis significantly reduces HIV-1 infection in these macrophages. Glycolysis is essential for tunneling nanotubes formation, which facilitates viral transfer and cell-to-cell fusion. Importantly, HIF-1α activation contributes to these processes. Overall, these data might facilitate the development of targeted therapies aimed at inhibiting HIF-1α–dependent glycolytic activity in TB-induced immunomodulatory macrophages to ultimately halt HIV-1 dissemination in coinfected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Toulouse, France.
- International Research Project CNRS "MAC-TB/HIV", Toulouse, France.
- Institut des Maladies Métaboliques et Cardiovasculaires, Inserm, Toulouse, France.
- Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS UMR9004, Montpellier, France.
- Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.
- Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS)-CONICET, Universidad de Buenos Aires, Buenos Aires, Argentina.
ORCID-Profile: Sarah C Monard, Fabien Blanchet, Geanncarlo Lugo-Villarino, Christel Vérollet
Förderung
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- Agence Nationale de la Recherche
Zitieren
APA
Vahlas, Z., Deyts, C., Fried, S., Ben Neji, M., Pingret, M., Faivre, N., Monard, S. C., Hertel, Q., Maio, M., Barros, J., Lucas, A., Vu Manh, T. P., Corti, M., Poincloux, R., Blanchet, F., Raynaud-Messina, B., Letisse, F., Neyrolles, O., Lugo-Villarino, G., …, & Vérollet, C. (2026). Glycolysis inhibition in tuberculosis-driven metabolic rewiring reduces HIV-1 spread in macrophages. Life Science Alliance. https://doi.org/10.26508/lsa.202503333
Vancouver
Vahlas Z, Deyts C, Fried S, Ben Neji M, Pingret M, Faivre N, et al. Glycolysis inhibition in tuberculosis-driven metabolic rewiring reduces HIV-1 spread in macrophages. Life Science Alliance. 2026. doi:10.26508/lsa.202503333
BibTeX
@article{Vahlas2026,
author = {Vahlas, Zoï and Deyts, Clara and Fried, Steven and Ben Neji, Myriam and Pingret, Maxime and Faivre, Natacha and Monard, Sarah C and Hertel, Quentin and Maio, Mariano and Barros, Joaquina and Lucas, Alexandre and Vu Manh, Thien Phong and Corti, Marcelo and Poincloux, Renaud and Blanchet, Fabien and Raynaud-Messina, Brigitte and Letisse, Fabien and Neyrolles, Olivier and Lugo-Villarino, Geanncarlo and Balboa, Luciana and Vérollet, Christel},
title = {Glycolysis inhibition in tuberculosis-driven metabolic rewiring reduces HIV-1 spread in macrophages},
journal = {Life Science Alliance},
year = {2026},
doi = {10.26508/lsa.202503333}
}
EUVIMED